PTCT - PTC Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$98.00
DETAILS
HIGH:
$120.00
LOW:
$82.00
MEDIAN:
$94.00
CONSENSUS:
$98.00
UPSIDE:
42.42%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,640,381 | $111.8M | 0.1% | -104,610 | DECREASED |
| Dalio | 0 | $0 | -- | -16,229 | SOLD |
| Greenblatt | 0 | $0 | -- | -16,259 | SOLD |
| Wood | 0 | $0 | -- | -1,128,551 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-15 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 2,356 | $72.08 | $170K |
| 2026-05-15 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 456 | $72.67 | $33K |
| 2026-05-15 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | M-Exempt | 2,812 | $25.69 | $72K |
| 2026-05-13 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 12,500 | -- | -- |
| 2026-05-14 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 679 | $73.06 | $50K |
| 2026-05-14 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 2,100 | $73.08 | $153K |
| 2026-05-14 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 2,572 | $72.46 | $186K |
| 2026-05-14 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 7,221 | $73.08 | $528K |
| 2026-05-08 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 600 | $79.28 | $48K |
| 2026-05-08 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 840 | $78.23 | $66K |
| 2026-05-08 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 200 | $78.00 | $16K |
| 2026-05-08 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | M-Exempt | 800 | $46.54 | $37K |
| 2026-05-08 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 1,900 | $79.31 | $151K |
| 2026-05-08 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | M-Exempt | 2,740 | $46.54 | $128K |
| 2026-04-21 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 2,850 | $70.91 | $202K |
| 2026-04-06 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 1,443 | $69.75 | $101K |
| 2026-04-06 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | M-Exempt | 2,265 | $39.42 | $89K |
| 2026-04-06 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 822 | $68.91 | $57K |
| 2026-04-02 | Golden Lee Scott | officer: EVP & CHIEF MEDICAL OFFICER | SELL | 829 | $67.99 | $56K |
| 2026-04-01 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | SELL | 39,393 | $68.89 | $2.7M |
| 2026-04-01 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | SELL | 12,530 | $69.50 | $871K |
| 2026-04-01 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | SELL | 80 | $70.30 | $6K |
| 2026-03-24 | Chutter Jessica Caroline | director | A-Award | 3,333 | -- | -- |
| 2026-03-24 | Chutter Jessica Caroline | director | A-Award | 4,000 | -- | -- |
| 2026-03-24 | Chutter Jessica Caroline | director | A-Award | 2,896 | $64.54 | $187K |